These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16769724)

  • 1. Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase.
    Zimny J; Sikora M; Guranowski A; Jakubowski H
    J Biol Chem; 2006 Aug; 281(32):22485-92. PubMed ID: 16769724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms that protect against homocysteine toxicity].
    Zimny J
    Postepy Biochem; 2008; 54(1):91-8. PubMed ID: 18610586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase.
    Borowczyk K; Tisończyk J; Jakubowski H
    Amino Acids; 2012 Sep; 43(3):1339-48. PubMed ID: 22227865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of homocysteine-thiolactone in plants.
    Jakubowski H; Guranowski A
    J Biol Chem; 2003 Feb; 278(9):6765-70. PubMed ID: 12496251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans.
    Jakubowski H
    Clin Chem Lab Med; 2003 Nov; 41(11):1462-6. PubMed ID: 14656026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
    Perla-Kaján J; Jakubowski H
    FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation.
    Jakubowski H
    J Biol Chem; 2000 Feb; 275(6):3957-62. PubMed ID: 10660550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and neurotoxicity of homocysteine thiolactone in mice: evidence for a protective role of paraoxonase 1.
    Borowczyk K; Shih DM; Jakubowski H
    J Alzheimers Dis; 2012; 30(2):225-31. PubMed ID: 22406444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
    Jakubowski H
    Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proofreading in vivo: editing of homocysteine by methionyl-tRNA synthetase in the yeast Saccharomyces cerevisiae.
    Jakubowski H
    EMBO J; 1991 Mar; 10(3):593-8. PubMed ID: 2001674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced homocysteine-thiolactonase activity in Alzheimer's disease.
    Suszynska J; Tisonczyk J; Lee HG; Smith MA; Jakubowski H
    J Alzheimers Dis; 2010; 19(4):1177-83. PubMed ID: 20308784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia and bleomycin hydrolase modulate the expression of mouse brain proteins involved in neurodegeneration.
    Suszyńska-Zajczyk J; Luczak M; Marczak L; Jakubowski H
    J Alzheimers Dis; 2014; 40(3):713-26. PubMed ID: 24496069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BLH1 codes for a yeast thiol aminopeptidase, the equivalent of mammalian bleomycin hydrolase.
    Enenkel C; Wolf DH
    J Biol Chem; 1993 Apr; 268(10):7036-43. PubMed ID: 8463237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
    Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
    FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
    Jakubowski H; Ambrosius WT; Pratt JH
    FEBS Lett; 2001 Feb; 491(1-2):35-9. PubMed ID: 11226414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.
    Perła-Kaján J; Borowczyk K; Głowacki R; Nygård O; Jakubowski H
    FASEB J; 2018 May; ():fj201800346R. PubMed ID: 29782204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological consequences of homocysteine excess.
    Jakubowski H
    J Nutr; 2006 Jun; 136(6 Suppl):1741S-1749S. PubMed ID: 16702349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of homocysteine toxicity in humans.
    Jakubowski H
    Cell Mol Life Sci; 2004 Feb; 61(4):470-87. PubMed ID: 14999406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cys102 and His398 are required for bleomycin-inactivating activity but not for hexamer formation of yeast bleomycin hydrolase.
    Pei Z; Sebti SM
    Biochemistry; 1996 Aug; 35(33):10751-6. PubMed ID: 8718865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.